31st January 2026, Saturday

Latest Posts

HealthTech News

  • Non-children’s hospitals more commonly use imaging exposing children to ionizing radiation
    on January 31, 2026 at 1:30 am

    Imaging modalities that expose children to ionizing radiation are used more frequently at non-children’s hospitals compared with children’s hospitals, according to a study published online Jan. 20 in the Journal of the American College of Radiology.

  • Elevated BMI, physical inactivity are metabolic drivers of hypertension-related chronic kidney disease
    on January 31, 2026 at 12:30 am

    Elevated body mass index (BMI) and physical inactivity are metabolic drivers of hypertension-related chronic kidney disease (HT-CKD), with elevated BMI exerting a greater impact, according to a study published online Jan. 11 in Frontiers in Nutrition.

  • RNA therapy may be a solution for infant hydrocephalus
    on January 30, 2026 at 10:30 pm

    Hydrocephalus is a life-threatening condition that occurs in about 1 in 1,000 newborns and is often treated with invasive surgery. Now, a new study offers hope of preventing hydrocephalus before it even occurs. The paper is published in the journal Molecular Therapy.

  • Laws to keep guns away from distressed individuals reduce suicides, suggests study
    on January 30, 2026 at 8:30 pm

    In 2023, more than half of all suicide deaths in the United States involved firearms. “Red flag” laws—also called Extreme Risk Protection Orders or ERPOs—are designed to reduce these deaths by authorizing temporary firearm removal from individuals deemed at high risk of harming themselves or others. ERPO laws had been implemented in 21 states and the District of Columbia as of February 2025.

  • Gut bacteria may tip the balance between feeding tumors and fueling immunity
    on January 30, 2026 at 7:40 pm

    A new study reveals how bacteria in the gut can help determine whether the amino acid asparagine from the diet will feed tumor growth or activate immune cells against the cancer, according to researchers at Weill Cornell Medicine. This casts the gut microbiome, comprising the trillions of microorganisms that live in the intestine, as a central player in the body’s response to cancer and to modern cancer treatments like immunotherapies.